BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 28460452)

  • 1. Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
    Lin Z; Neiswender J; Fang B; Ma X; Zhang J; Hu X
    Oncotarget; 2017 Apr; 8(16):26625-26636. PubMed ID: 28460452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer.
    Yang X; Zhang K; Zhang C; Peng R; Sun C
    BMC Cancer; 2019 May; 19(1):465. PubMed ID: 31101027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B; Pu K; Ge L; Wu X
    Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of circulating cell-free DNA as a diagnostic tool for breast cancer: an updated systematic review and meta-analysis of quantitative and qualitative ssays.
    Guo Q; Hua Y
    Clin Chem Lab Med; 2021 Aug; 59(9):1479-1500. PubMed ID: 33951758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
    Xie W; Xie L; Song X
    Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
    Zhou Y; Wang C; Zhu H; Lin Y; Pan B; Zhang X; Huang X; Xu Q; Xu Y; Sun Q
    PLoS One; 2016; 11(6):e0158143. PubMed ID: 27336598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis.
    Yu D; Tong Y; Guo X; Feng L; Jiang Z; Ying S; Jia J; Fang Y; Yu M; Xia H; Shi L; Lou J
    Front Oncol; 2019; 9():95. PubMed ID: 30881916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis.
    Huynh KQ; Le AT; Phan TT; Ho TT; Pho SP; Nguyen HT; Le BT; Nguyen TT; Nguyen ST
    Oxid Med Cell Longev; 2023; 2023():8379231. PubMed ID: 37122536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis.
    Zhang C; Chao F; Wang S; Han D; Chen G
    J Oncol; 2022; 2022():1505087. PubMed ID: 35669243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for breast cancer detection: An update meta-analysis.
    Dong H; Kang L; Cheng S; Zhang R
    Thorac Cancer; 2021 Dec; 12(23):3201-3207. PubMed ID: 34668649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
    Huang J; Chen J; Huang Q
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():35-42. PubMed ID: 30317143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta-analysis.
    Chu M; Fang Y; Jin Y
    J Clin Lab Anal; 2021 Sep; 35(9):e23934. PubMed ID: 34331339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
    Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM
    Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
    Huang YK; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB; Yan C
    PLoS One; 2015; 10(11):e0142080. PubMed ID: 26556485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meta-analysis on the diagnostic value of laser Doppler imaging for burn depth].
    Huang Y; Qiu L; Mei AL; Li JX
    Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):301-308. PubMed ID: 28651422
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Zhou Q; Li W; Leng B; Zheng W; He Z; Zuo M; Chen A
    PLoS One; 2016; 11(6):e0155495. PubMed ID: 27253331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta-analysis.
    Zhu Y; Yang T; Wu Q; Yang X; Hao J; Deng X; Yang S; Gu C; Wang Z
    Cancer Med; 2020 Aug; 9(16):5699-5707. PubMed ID: 32628360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of circulating-free DNA for the determination of hepatocellular carcinoma: a systematic review and meta-analysis.
    Yinzhong W; Miaomiao W; Xiaoxue T; Qian W; Meng Q; Junqiang L
    Expert Rev Mol Diagn; 2023 Jan; 23(1):63-69. PubMed ID: 36633401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.